Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Medicines-Generic'

Medicines-Generic published presentations and documents on DocSlides.

Generic Medicines When chemical medicines are first developed and approved, they are sold by a phar
Generic Medicines When chemical medicines are first developed and approved, they are sold by a phar
by angelina
Once . the protection of the product . expires for...
Value of generic medicines
Value of generic medicines
by conchita-marotz
PARTNERSHIP. Medicines for Europe Vision 2020 . O...
The volume share of generic medicines in the
The volume share of generic medicines in the
by phoebe-click
retail . market between 1999 and 2009: a comparis...
Medicines Session Medicines Information Medicines
Medicines Session Medicines Information Medicines
by edwin
Basic enquiry answering. September . 2016. Session...
Price Declines after Branded Medicines Lose Exclusivity in the USJan
Price Declines after Branded Medicines Lose Exclusivity in the USJan
by amey
IMS Institute for Healthcare Informatics, 100 IMS ...
The generic and biosimilar
The generic and biosimilar
by alida-meadow
perspective. Warwick Smith. Director General BGMA...
Herbal Medicines Herbal medicines are extracted from plants, or parts of plants that are thought to
Herbal Medicines Herbal medicines are extracted from plants, or parts of plants that are thought to
by stefany-barnette
Herbal preparations . could . be regarded as the ...
Medicines should help you stay healthy and live longer!
Medicines should help you stay healthy and live longer!
by CountryBumpkin
If you want to know more or are worried about your...
Introduction to regulation of medicines and health technolo
Introduction to regulation of medicines and health technolo
by pamella-moone
Global context of drug regulation. Dr Lembit Räg...
Policy ptions for romoting the se of eneric edicines in and iddleincom
Policy ptions for romoting the se of eneric edicines in and iddleincom
by sophie
LicensingThis report is licensed under theCreative...
quality 149 patients 149 value 149 sustainability 149 part
quality 149 patients 149 value 149 sustainability 149 part
by angelina
Value of generic medicines PARTNERSHIP Medicines ...
Economic characteristics
Economic characteristics
by conchita-marotz
of pharmaceuticals. .. Jamasoft2017. 1. Jamasoft2...
Economic characteristics
Economic characteristics
by phoebe-click
of pharmaceuticals. .. Jamasoft2017. 1. Jamasoft2...
Value of
Value of
by tatyana-admore
generic. . medicines. PARTNERSHIP. Medicines for...
Helen Gregory
Helen Gregory
by lindy-dunigan
Lead Medicines Management Technician. North Derby...
Pharmaceutical Patents,
Pharmaceutical Patents,
by stefany-barnette
TRIPS Flexibilities and . Access to Medicines in ...
Please make this a banner 1.3m long and about 12 cm deep an
Please make this a banner 1.3m long and about 12 cm deep an
by briana-ranney
BUILDING CONSUMER CONFIDENCE IN GENERIC MEDICINES...
Branded generic drug saving
Branded generic drug saving
by cappi
1 of 6 This bulletin focuses on the prescribing of...
Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient
Generic treatments for HIV, HBV, HCV, TB could be mass produced for <$90 per patient
by min-jolicoeur
Dr Dzintars Gotham MBBS BSc(Hons). on behalf of. ...
Barriers to access to innovative medicines
Barriers to access to innovative medicines
by ameer
Dr. Richard Torbett. Chief Economist, EFPIA. Chin...
Large scale evidence generation for the utilisation and safety of biologic medicines
Large scale evidence generation for the utilisation and safety of biologic medicines
by quinn
. Associate Professor Nicole Pratt . Quality use o...
Discharge Medicines Service (DMS) Event
Discharge Medicines Service (DMS) Event
by ceila
15 November 2022. Agenda. 7:00pm . Introduction,...
Disease Burden, Costs and Access to Valuable Cancer Medicines: 
Disease Burden, Costs and Access to Valuable Cancer Medicines: 
by osullivan
how . the pandemic has influenced the disease burd...
Pharmacy & Medicines Management
Pharmacy & Medicines Management
by madeline
2018. Objectives. Prescribing & Zero tolerance...
Introduction to Homeopathic Medicines
Introduction to Homeopathic Medicines
by anderson
V2 10/14. Disclosure:. Richard Mudd, National Phar...
Medicines Manufacturing in the UK 2017
Medicines Manufacturing in the UK 2017
by skylar
Medicines Manufacturing in the UK 2017. Welcome by...
A n introduction to medicines development and regulation
A n introduction to medicines development and regulation
by jordyn
UKMi Horizon Scanning Working Group. Jim Glare. We...
Treatment Use of Unlicensed Medicines
Treatment Use of Unlicensed Medicines
by gelbero
GS K Public P ol icy Position ...
The Falsified Medicines Directive
The Falsified Medicines Directive
by TropicalParadise
The . HDA (formerly BAPW) . Who we are. Good Distr...
Getting the most out of your Arthritis medicines & your Pharmacist
Getting the most out of your Arthritis medicines & your Pharmacist
by cora
Kathy Maxwell. Community Pharmacist. Hillpark. Ca...
Taking medicines safely and effectively
Taking medicines safely and effectively
by elena
In this presentation we want to help you to know a...
WHO Essential Medicines List
WHO Essential Medicines List
by badra
Concept and Process. IPC Meeting. June 6, 2014 –...
EUROPEAN MEDICINES AGENCY
EUROPEAN MEDICINES AGENCY
by roberts
ealtEMA Regulatory Science to 2025Strategic rex006...
STATISTICS ON MEDICINES
STATISTICS ON MEDICINES
by lily
kD 0A4S2UA 34A43TIKA CONSUMPTION2016x0080i tAT AH9...
Reflections on The Long Last Mile: Challenges of Access to Medicines and Comprehensive
Reflections on The Long Last Mile: Challenges of Access to Medicines and Comprehensive
by chaptoe
Case Management. George Jagoe . EVP, Access & ...
Biodiversity and Availability of Medicines
Biodiversity and Availability of Medicines
by rivernescafe
By. Isma’eel Umar Yunus. BPharm., RPh.. African ...
Short Update WHO Essential Medicines and Health products
Short Update WHO Essential Medicines and Health products
by jane-oiler
IPC Meeting . 4 to 6 . June. 2014. Essential Med...
Access to medicines and health technologies for NCDs
Access to medicines and health technologies for NCDs
by marina-yarberry
Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter ....
Medicines About the team
Medicines About the team
by lois-ondreau
Claire Vaughan Head of Meds Optimisation . Lind...
Key aspects of managing a medicines benefit program – Functions (1)
Key aspects of managing a medicines benefit program – Functions (1)
by kittie-lecroy
Defining conditions to cover. Defining and updati...